# Biopsy-Proven Gastric Pathological Findings in Mechanically Ventilated Intensive Care Unit Patients

**Authors:** Elvan Tekir Yılmaz, Bilge Olgun Keleş

PMC · DOI: 10.7759/cureus.61744 · Cureus · 2024-06-05

## TL;DR

This study found that critically ill ICU patients on mechanical ventilation have lower Helicobacter pylori activity compared to the general population, suggesting a lower risk of gastric issues.

## Contribution

The study provides new insights into H. pylori prevalence in ICU patients and its relation to gastric pathology.

## Key findings

- H. pylori positivity was significantly lower in ICU patients (11.4%) compared to the general population (31.8%).
- ICU patients had lower hemoglobin and hematocrit levels compared to the ED group.
- There was no significant difference in the incidence of atrophic gastritis and intestinal metaplasia between the groups.

## Abstract

Objectives

Helicobacter pylori (H. pylori) is known to affect a large proportion of the world population. It plays a role in the pathogenesis of peptic ulcer (PU) and increases the likelihood of bleeding. In critically ill patients in intensive care units (ICUs), the risk of bleeding may be much higher due to many concomitant factors. The study aimed to determine the activation of H. pylori in mechanically ventilated (MV) intensive care patients and compare this with the general population.

Methods

This study was performed retrospectively by screening patients who underwent esophagogastroduodenoscopy and histopathological sampling in our hospital between January and June 2023. The study included 79 patients aged between 18 and 85 years. The patients were categorized into two groups: 35 patients in the ICU with mechanical ventilation (MV) support (EMV) and 44 patients who presented to the gastroenterology department due to dyspeptic symptoms and underwent endoscopy (ED). Age; sex characteristics; laboratory parameters such as hemoglobin (Hb), hematocrit (Htc), mean cellular volume (MCV), white blood cell (WBC), neutrophil, platelet, glucose, urea, creatinine, aspartate transaminase (AST), alanine transaminase (ALT), C-reactive protein (CRP), albumin, ferritin, thyroid-stimulating hormone (TSH), anti-hepatitis C virus (HCV), hepatitis B surface antigen (HBsAg), anti-HIV; and biopsy results (H. pylori positivity, intestinal metaplasia, and atrophy) were recorded.

Results

A total of 79 patients who underwent gastric biopsy were assessed. There were 35 patients in the EMV group and 44 patients in the ED group. There was no difference in gender and age distribution between the groups. Hb and Htc were significantly lower in EMV compared to ED (p=0.001). Hb was 9.4±1.7 g/dL in EMV and 10.8±2.1 g/dL in ED. Htc was 29.6±5.1 in EMV and 33.5±5.7 in ED. MCV, WBC, glucose, urea, AST, ALT, CRP, and ferritin values were statistically significantly higher in EMV (p<0.05). Albumin and creatinine levels were statistically significantly lower in EMV (p<0.05). There was no significant difference between the groups in terms of neutrophils, platelets, and TSH. In the EMV group, H. pylori activity was negative in 31 (88.6%) patients and positive in four (11.4%) patients. In the ED group, H. pylori activity was negative in 30 (68.2%) patients and positive in 14 (31.8%) patients. There was a statistically significant difference between the groups in terms of H. pylori positivity (p=0.032).

Conclusions

The prevalence of H. pylori in MV patients in the ICU is low compared to the average population. The incidence of atrophic gastritis and intestinal metaplasia is the same. The present study supports that ICU cases do not have a higher risk of gastric premalignant lesions compared to the average population.

## Linked entities

- **Diseases:** peptic ulcer (MONDO:0004247), atrophic gastritis (MONDO:0006665), intestinal metaplasia (MONDO:0100190)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** gastric premalignant lesions (MESH:D013272), atrophy (MESH:D001284), critically ill (MESH:D016638), bleeding (MESH:D006470), intestinal metaplasia (MESH:D007410), atrophic gastritis (MESH:D005757), dyspeptic symptoms (MESH:D012816), PU (MESH:D010437)
- **Chemicals:** EMV (MESH:C083858), urea (MESH:D014508), glucose (MESH:D005947), creatinine (MESH:D003404)
- **Species:** Homo sapiens (human, species) [taxon 9606], hepatitis C virus [taxon 11103], Helicobacter pylori (species) [taxon 210], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11226191/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC11226191/full.md

---
Source: https://tomesphere.com/paper/PMC11226191